Given the proposed acquisition of Shockwave Medical by Johnson & Johnson, Shockwave Medical is withdrawing its full year 2024 guidance, previously issued on February 15, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
334.8 USD | -0.02% |
|
-.--% | +75.67% |
Jul. 01 | Momentum Picks Q3 2024: 5 stocks for the summer | ![]() |
Jun. 03 | Shockwave Medical, Inc.(NasdaqGS:SWAV) dropped from S&P 1000 | CI |
1st Jan change | Capi. | |
---|---|---|
+75.67% | 12.57B | |
-28.01% | 7.02B | |
+10.01% | 5.24B | |
-18.23% | 4.76B | |
+15.57% | 4.11B | |
-22.78% | 3.74B | |
-20.84% | 2.99B | |
-1.24% | 2B | |
+12.39% | 1.81B | |
-4.11% | 1.72B |
- Stock Market
- Equities
- SWAV Stock
- News Shockwave Medical
- Shockwave Medical Withdraws Earnings Guidance for the Full Year 2024